Patents Assigned to Acrux DDS PTY LTD
-
Patent number: 10449343Abstract: This invention relates to a device, a system and a method for applying a volume of liquid to a treatment surface. The device includes a container for containing the liquid, a pump for extracting liquid from the container, an actuator for operating the pump, and a collapsible receptacle for accommodating extracted liquid.Type: GrantFiled: November 25, 2014Date of Patent: October 22, 2019Assignee: ACRUX DDS PTY LTDInventors: Shu Kuen Chang, Alain Regard, Anastasios G Karahalios, Mark LaFever
-
Publication number: 20170157377Abstract: This invention relates to a device, a system and a method for applying a volume of liquid to a treatment surface. The device includes a container for containing the liquid, a pump for extracting liquid from the container, an actuator for operating the pump, and a collapsible receptacle for accommodating extracted liquid.Type: ApplicationFiled: November 25, 2014Publication date: June 8, 2017Applicant: Acrux DDS Pty Ltd.Inventors: Shu Kuen Chang, Alain Regard, Anastasios G. Karahalios, Mark LaFever
-
Publication number: 20170157378Abstract: This invention relates to a device, a system and a method for applying a volume of liquid to a treatment surface. The device includes a container for containing the liquid, a pump for extracting liquid from the container, an actuator for operating the pump, and a collapsible receptacle for accommodating extracted liquid.Type: ApplicationFiled: November 25, 2014Publication date: June 8, 2017Applicant: ACRUX DDS PTY LTDInventors: Shu Kuen Chang, Alain Regard, Anastasios G. Karahalios, Mark LaFever
-
Publication number: 20160303359Abstract: An implement for applying a volume of liquid to a treatment surface includes a support onto which is mounted a receptacle. The receptacle defines a reservoir space which receives the liquid. The receptacle includes a wall having a working surface that is used to spread the liquid over the treatment surface. The wall is resiliently deformable such that in use the working surface maintains contact with the treatment surface when spreading the liquid. The implement is used in applying a transdermal lotion to the axilla area of a user. A system for transdermal administration of a physiological active agent from a liquid composition and a method of conducting the same are also provided.Type: ApplicationFiled: February 18, 2016Publication date: October 20, 2016Applicant: Acrux DDS Pty LtdInventors: Peter BAYLY, Mark Simon Bayly, Magnus Ahlstrom, Adam Charles Watkinson
-
Publication number: 20160250227Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.Type: ApplicationFiled: October 6, 2015Publication date: September 1, 2016Applicant: Acrux DDS Pty LtdInventors: Tony DIPIETRO, Andrew HUMBERSTONE, Igor GONDA, Adam WATKINSON, Kerrie SETIAWAN, Nina WILKINS
-
Patent number: 9289586Abstract: An implement for applying a volume of liquid to a treatment surface includes a support onto which is mounted a receptacle. The receptacle defines a reservoir space which receives the liquid. The receptacle includes a wall having a working surface that is used to spread the liquid over the treatment surface. The wall is resiliently deformable such that in use the working surface maintains contact with the treatment surface when spreading the liquid. The implement is used in applying a transdermal lotion to the axilla area of a user. A system for transdermal administration of a physiological active agent from a liquid composition and a method of conducting the same are also provided.Type: GrantFiled: June 27, 2014Date of Patent: March 22, 2016Assignee: ACRUX DDS PTY LTDInventors: Peter Bayly, Mark Simon Bayly, Magnus Ahlstrom, Adam Charles Watkinson
-
Publication number: 20160022820Abstract: A transdermal delivery system comprising a composition comprising a physiologically active agent and a penetration enhancer wherein the penetration enhancer comprises a combination of (i) an ester of salicylic acid, preferably selected from the C6 to C30 aliphatic ester of salicylic acid and (ii) polyethylene glycol (PEG) of average molecular weight no more than 300.Type: ApplicationFiled: June 10, 2015Publication date: January 28, 2016Applicant: Acrux DDS Pty Ltd.Inventors: Kerrie Setiawan, Adam Watkinson
-
Patent number: 9180194Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.Type: GrantFiled: October 8, 2014Date of Patent: November 10, 2015Assignee: ACRUX DDS PTY LTDInventors: Tony Dipietro, Andrew Humberstone, Igor Gonda, Adam Watkinson, Kerrie Setiawan, Nina Wilkins
-
Patent number: 9078810Abstract: A transdermal delivery system comprising a composition comprising a physiologically active agent and a penetration enhancer wherein the penetration enhancer comprises a combination of (i) an ester of salicylic acid, preferably selected from the C6 to C30 aliphatic ester of salicylic acid and (ii) polyethylene glycol (PEG) of average molecular weight no more than 300.Type: GrantFiled: May 6, 2013Date of Patent: July 14, 2015Assignee: ACRUX DDS PTY LTDInventors: Kerrie Setiawan, Adam Watkinson
-
Publication number: 20150094290Abstract: A pharmaceutical composition for transdermal delivery comprising one or more physiologically active agents; one or more dermal penetration enhancers; and a volatile pharmaceutically acceptable carrier comprising a volatile solvent; and wherein the physiologically active agent and dermal penetration enhancer form an amorphous deposit upon evaporation of the volatile carrier, said amorphous deposit forming a reservoir within the stratum corneum; and (A) wherein the composition has a release rate profile of physiologically active agent so as to provide a ratio of the maximum concentration (Cmax) to the average concentration (Cavg) for the physiologically active agent over the dosage interval within the range of 1 to 10.Type: ApplicationFiled: June 16, 2014Publication date: April 2, 2015Applicant: Acrux DDS Pty LtdInventors: Timothy Matthias Morgan, Nina Frances Wilkins, Kathryn Traci-Jane Klose, Barrie Charles Finnin, Barry Leonard Reed
-
Patent number: 8993520Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.Type: GrantFiled: June 25, 2010Date of Patent: March 31, 2015Assignee: Acrux DDS Pty LtdInventors: Tony Dipietro, Andrew Humberstone, Igor Gonda, Adam Watkinson, Kerrie Setiawan, Nina Wilkins
-
Publication number: 20150088080Abstract: This invention relates to an implement 1 for applying a volume of liquid to a treatment surface. The implement includes a support means 3 onto which is mounted a receptacle 2, the receptacle defining a reservoir space 4 which receives the liquid. The receptacle includes a wall 6 having a working surface that is used to spread the liquid over the treatment surface. The wall 6 is resiliently deformable so in use the working surface maintains contact with the treatment surface when spreading the liquid. The implement has a specific application in applying a transdermal lotion to the axilla area of the user. The invention also relates to a system for transdermal administration of a physiological active agent from a liquid composition and a method of conducting the same.Type: ApplicationFiled: June 27, 2014Publication date: March 26, 2015Applicant: Acrux DDS Pty LtdInventors: Peter Bayly, Mark Simon Bayly, Magnus Ahlstrom, Adam Charles Watkinson
-
Publication number: 20150087623Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.Type: ApplicationFiled: October 8, 2014Publication date: March 26, 2015Applicant: Acrux DDS Pty LtdInventors: Tony DIPIETRO, Andrew HUMBERSTONE, Igor GONDA, Adam WATKINSON, Kerrie SETIAWAN, Nina WILKINS
-
Patent number: 8807861Abstract: An implement 1 for applying a volume of liquid to a treatment surface can include a support 3 onto which is mounted a receptacle 2, the receptacle defining a reservoir space 4 which receives the liquid. The receptacle includes a wall 6 having a working surface that is used to spread the liquid over the treatment surface. The wall 6 is resiliently deformable so in use the working surface maintains contact with the treatment surface when spreading the liquid. The implement has a specific application in applying a transdermal lotion to the axilla area of the user. A system for transdermal administration of a physiological active agent from a liquid composition and a method of using this system are described.Type: GrantFiled: March 15, 2013Date of Patent: August 19, 2014Assignee: Acrux DDS Pty Ltd.Inventors: Peter Bayly, Mark Simon Bayly, Magnus Ahlstrom, Adam Charles Watkinson
-
Publication number: 20130316996Abstract: A pharmaceutical composition for transdermal delivery comprising one or more physiologically active agents; one or more dermal penetration enhancers; and a volatile pharmaceutically acceptable carrier comprising a volatile solvent; and wherein the physiologically active agent and dermal penetration enhancer form an amorphous deposit upon evaporation of the volatile carrier, said amorphous deposit forming a reservoir within the stratum corneum; and (A) wherein the composition has a release rate profile of physiologically active agent so as to provide a ratio of the maximum concentration (Cmax) to the average concentration (Cavg) for the physiologically active agent over the dosage interval within the range of 1 to 10.Type: ApplicationFiled: December 11, 2012Publication date: November 28, 2013Applicant: Acrux DDS Pty LtdInventor: Acrux DDS Pty Ltd
-
Publication number: 20130317122Abstract: A transdermal delivery system comprising a composition comprising a physiologically active agent and a penetration enhancer wherein the penetration enhancer comprises a combination of (i) an ester of salicylic acid, preferably selected from the C6 to C30 aliphatic ester of salicylic acid and (ii) polyethylene glycol (PEG) of average molecular weight no more than 300.Type: ApplicationFiled: May 6, 2013Publication date: November 28, 2013Applicant: Acrux DDs Pty Ltd.Inventors: Kerrie Setiawan, Adam Watkinson
-
Publication number: 20130317462Abstract: A transdermal delivery system comprising a composition comprising a pharmacological agent and a penetration enhancer wherein the penetration enhancer comprises polyethylene glycol (PEG) of average molecular weight no more than 300.Type: ApplicationFiled: May 6, 2013Publication date: November 28, 2013Applicant: Acrux DDS Pty Ltd.Inventors: Kerrie Setiawan, Adam Watkinson
-
Publication number: 20130211350Abstract: This invention relates to an implement 1 for applying a volume of liquid to a treatment surface. The implement includes a support means 3 onto which is mounted a receptacle 2, the receptacle defining a reservoir space 4 which receives the liquid. The receptacle includes a wall 6 having a working surface that is used to spread the liquid over the treatment surface. The wall 6 is resiliently deformable so in use the working surface maintains contact with the treatment surface when spreading the liquid. The implement has a specific application in applying a transdermal lotion to the axilla area of the user. The invention also relates to a system for transdermal administration of a physiological active agent from a liquid composition and a method of conducting the same.Type: ApplicationFiled: March 15, 2013Publication date: August 15, 2013Applicant: Acrux DDS Pty LtdInventor: Acrux DDS Pty Ltd
-
Patent number: D749225Type: GrantFiled: November 26, 2013Date of Patent: February 9, 2016Assignee: ACRUX DDS PTY LTDInventors: Shu Kuen Chang, Alain Regard, Anastasios G. Karahalios, Mark LaFever
-
Patent number: D750788Type: GrantFiled: November 26, 2013Date of Patent: March 1, 2016Assignee: ACRUX DDS PTY LTDInventors: Shu Kuen Chang, Alain Regard, Anastasios G. Karahalios, Mark LaFever